학술논문
Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors
Document Type
Article
Author
Source
In: Investigational New Drugs . (Investigational New Drugs, 1 February 2018, 36(1):85-95)
Subject
Language
English
ISSN
15730646
01676997
01676997